Non-Opioid Pain Treatment Market 2027 By Products, Application | The Insight Partners

Non-Opioid Pain Treatment Market to 2027 - Global Analysis and Forecasts By Products (Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived); Application (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Other Pain)

Report Code: TIPRE00004769 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Non-opioid pain treatment is a kind of treatment used for mild to moderate pain treatment. These treatments are prominent during chronic disease such as cancer, arthritis, diabetes etc.

MARKET DYNAMICS
The Non-opioid pain treatment market is anticipated to grow in the forecast period owing to driving factors such as rising population of geriatric patients, and easy and effective medications during the treatment, better health facilities. Nevertheless, preference for alternative therapies and fake products present in the market is expected to hinder the market growth during the forecast period.

MARKET SCOPE
The "Global Non-opioid pain treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Non-opioid pain treatment market with detailed market segmentation by Dosage, Route of Administration, Application and geography. The global Non-opioid pain treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Non-opioid pain treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Non-opioid pain treatment market is segmented on the basis of Products and Application. Based on Product the market is segmented into Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived. Based on Application the market is segmented into Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Other Pain.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Non-opioid pain treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Non-opioid pain treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Non-opioid pain treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Non-opioid pain treatment market in these regions.

MARKET PLAYERS
The reports cover key developments in the Non-opioid pain treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Non-opioid pain treatment Market are anticipated to lucrative growth opportunities in the future with the rising demand for Non-opioid pain treatment in the global market. Below mentioned is the list of few companies engaged in the Non-opioid pain treatment market.

The report also includes the profiles of key Non-opioid pain treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Allergan PLC
  • Aurora
  • Canopy Growth Corp.
  • GW Pharmaceuticals
  • Medical Marijuana Inc.
  • Medropharm Gmbh
  • Panag Pharma Inc.
  • Tilray
  • US Worldmeds LLC
  • Vanway
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non-opioid Pain Treatment Market - By Products
1.3.2 Non-opioid Pain Treatment Market - By Application
1.3.3 Non-opioid Pain Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON-OPIOID PAIN TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NON-OPIOID PAIN TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON-OPIOID PAIN TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. NON-OPIOID PAIN TREATMENT - GLOBAL MARKET OVERVIEW
6.2. NON-OPIOID PAIN TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NON-OPIOID PAIN TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCTS
7.1. OVERVIEW
7.2. PRODUCTS MARKET FORECASTS AND ANALYSIS
7.3. MEDICAL CANNABIS
7.3.1. Overview
7.3.2. Medical Cannabis Market Forecast and Analysis
7.4. MENTHOL-CONTAINING
7.4.1. Overview
7.4.2. Menthol-Containing Market Forecast and Analysis
7.5. OMEGA 3 FATTY ACID-CONTAINING
7.5.1. Overview
7.5.2. Omega 3 Fatty Acid-Containing Market Forecast and Analysis
7.6. BOTULINUM TOXINS
7.6.1. Overview
7.6.2. Botulinum Toxins Market Forecast and Analysis
7.7. CAPSAICIN-DERIVED
7.7.1. Overview
7.7.2. Capsaicin-Derived Market Forecast and Analysis
8. NON-OPIOID PAIN TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ORTHOPAEDIC AND MUSCULOSKELETAL PAIN
8.3.1. Overview
8.3.2. Orthopaedic and Musculoskeletal Pain Market Forecast and Analysis
8.4. NEUROPATHIC PAIN
8.4.1. Overview
8.4.2. Neuropathic Pain Market Forecast and Analysis
8.5. CANCER PAIN
8.5.1. Overview
8.5.2. Cancer Pain Market Forecast and Analysis
8.6. OTHER PAIN.
8.6.1. Overview
8.6.2. Other Pain. Market Forecast and Analysis
9. NON-OPIOID PAIN TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Non-opioid Pain Treatment Market Overview
9.1.2 North America Non-opioid Pain Treatment Market Forecasts and Analysis
9.1.3 North America Non-opioid Pain Treatment Market Forecasts and Analysis - By Products
9.1.4 North America Non-opioid Pain Treatment Market Forecasts and Analysis - By Application
9.1.5 North America Non-opioid Pain Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Non-opioid Pain Treatment Market
9.1.5.1.1 United States Non-opioid Pain Treatment Market by Products
9.1.5.1.2 United States Non-opioid Pain Treatment Market by Application
9.1.5.2 Canada Non-opioid Pain Treatment Market
9.1.5.2.1 Canada Non-opioid Pain Treatment Market by Products
9.1.5.2.2 Canada Non-opioid Pain Treatment Market by Application
9.1.5.3 Mexico Non-opioid Pain Treatment Market
9.1.5.3.1 Mexico Non-opioid Pain Treatment Market by Products
9.1.5.3.2 Mexico Non-opioid Pain Treatment Market by Application
9.1.5.4 US Non-opioid Pain Treatment Market
9.1.5.4.1 US Non-opioid Pain Treatment Market by Products
9.1.5.4.2 US Non-opioid Pain Treatment Market by Application
9.2. EUROPE
9.2.1 Europe Non-opioid Pain Treatment Market Overview
9.2.2 Europe Non-opioid Pain Treatment Market Forecasts and Analysis
9.2.3 Europe Non-opioid Pain Treatment Market Forecasts and Analysis - By Products
9.2.4 Europe Non-opioid Pain Treatment Market Forecasts and Analysis - By Application
9.2.5 Europe Non-opioid Pain Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Non-opioid Pain Treatment Market
9.2.5.1.1 Germany Non-opioid Pain Treatment Market by Products
9.2.5.1.2 Germany Non-opioid Pain Treatment Market by Application
9.2.5.2 France Non-opioid Pain Treatment Market
9.2.5.2.1 France Non-opioid Pain Treatment Market by Products
9.2.5.2.2 France Non-opioid Pain Treatment Market by Application
9.2.5.3 Italy Non-opioid Pain Treatment Market
9.2.5.3.1 Italy Non-opioid Pain Treatment Market by Products
9.2.5.3.2 Italy Non-opioid Pain Treatment Market by Application
9.2.5.4 Spain Non-opioid Pain Treatment Market
9.2.5.4.1 Spain Non-opioid Pain Treatment Market by Products
9.2.5.4.2 Spain Non-opioid Pain Treatment Market by Application
9.2.5.5 United Kingdom Non-opioid Pain Treatment Market
9.2.5.5.1 United Kingdom Non-opioid Pain Treatment Market by Products
9.2.5.5.2 United Kingdom Non-opioid Pain Treatment Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Non-opioid Pain Treatment Market Overview
9.3.2 Asia-Pacific Non-opioid Pain Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Non-opioid Pain Treatment Market Forecasts and Analysis - By Products
9.3.4 Asia-Pacific Non-opioid Pain Treatment Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Non-opioid Pain Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Non-opioid Pain Treatment Market
9.3.5.1.1 Australia Non-opioid Pain Treatment Market by Products
9.3.5.1.2 Australia Non-opioid Pain Treatment Market by Application
9.3.5.2 China Non-opioid Pain Treatment Market
9.3.5.2.1 China Non-opioid Pain Treatment Market by Products
9.3.5.2.2 China Non-opioid Pain Treatment Market by Application
9.3.5.3 India Non-opioid Pain Treatment Market
9.3.5.3.1 India Non-opioid Pain Treatment Market by Products
9.3.5.3.2 India Non-opioid Pain Treatment Market by Application
9.3.5.4 Japan Non-opioid Pain Treatment Market
9.3.5.4.1 Japan Non-opioid Pain Treatment Market by Products
9.3.5.4.2 Japan Non-opioid Pain Treatment Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Non-opioid Pain Treatment Market Overview
9.4.2 Middle East and Africa Non-opioid Pain Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Non-opioid Pain Treatment Market Forecasts and Analysis - By Products
9.4.4 Middle East and Africa Non-opioid Pain Treatment Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Non-opioid Pain Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Non-opioid Pain Treatment Market
9.4.5.1.1 South Africa Non-opioid Pain Treatment Market by Products
9.4.5.1.2 South Africa Non-opioid Pain Treatment Market by Application
9.4.5.2 Saudi Arabia Non-opioid Pain Treatment Market
9.4.5.2.1 Saudi Arabia Non-opioid Pain Treatment Market by Products
9.4.5.2.2 Saudi Arabia Non-opioid Pain Treatment Market by Application
9.4.5.3 U.A.E Non-opioid Pain Treatment Market
9.4.5.3.1 U.A.E Non-opioid Pain Treatment Market by Products
9.4.5.3.2 U.A.E Non-opioid Pain Treatment Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Non-opioid Pain Treatment Market Overview
9.5.2 South and Central America Non-opioid Pain Treatment Market Forecasts and Analysis
9.5.3 South and Central America Non-opioid Pain Treatment Market Forecasts and Analysis - By Products
9.5.4 South and Central America Non-opioid Pain Treatment Market Forecasts and Analysis - By Application
9.5.5 South and Central America Non-opioid Pain Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Non-opioid Pain Treatment Market
9.5.5.1.1 Brazil Non-opioid Pain Treatment Market by Products
9.5.5.1.2 Brazil Non-opioid Pain Treatment Market by Application
9.5.5.2 Argentina Non-opioid Pain Treatment Market
9.5.5.2.1 Argentina Non-opioid Pain Treatment Market by Products
9.5.5.2.2 Argentina Non-opioid Pain Treatment Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NON-OPIOID PAIN TREATMENT MARKET, KEY COMPANY PROFILES
11.1. ALLERGAN PLC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AURORA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CANOPY GROWTH CORP
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GW PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MEDICAL MARIJUANA INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MEDROPHARM GMBH
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PANAG PHARMA INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TILRAY
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. US WORLDMEDS LLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VANWAY
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Allergan PLC
- Aurora
- Canopy Growth Corp.
- GW Pharmaceuticals
- Medical Marijuana Inc.
- Medropharm Gmbh
- Panag Pharma Inc.
- Tilray
- US Worldmeds LLC
- Vanway